Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 50 of 496 entries
View as:

A Study of the Safety, Tolerability, and Effects of Cobimetinib and GDC-0994 in Patients With Locally Advanced or Metastatic Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT02457793 Org: User:
Start: 06/16/15 End: 12/05/16 Due: 12/05/17

A Study of Sunitinib in Combination With Bevacizumab and Paclitaxel in Previously Untreated Patients With Metastatic Breast Cancer (SABRE-B)

Phase: N/A Priority: Normal
NCT ID: NCT00434356 Org: User:
Start: 03/31/07 End: - Due: -

A Study of Bevacizumab With Carboplatin and Paclitaxel Chemotherapy for the First-Line Treatment of Patients With Metastatic Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT00434252 Org: User:
Start: 02/28/07 End: 04/30/09 Due: 04/30/10

A Study of RO7105705 in Healthy Participants and Participants With Mild-to-Moderate Alzheimer's Disease

Phase: N/A Priority: Normal
NCT ID: NCT02820896 Org: User:
Start: 06/29/16 End: 06/26/17 Due: 06/26/18

A Study to Evaluate Efalizumab in Adults With Plaque Psoriasis, Including Those Who Are Receiving Concomitant Antipsoriatic Therapies

Phase: N/A Priority: Normal
NCT ID: NCT00338143 Org: User:
Start: 10/31/03 End: 05/31/04 Due: 05/31/05

A Study of Tenecteplase for Restoration of Function in Dysfunctional Hemodialysis Catheters

Phase: N/A Priority: Normal
NCT ID: NCT00396032 Org: User:
Start: 10/31/06 End: - Due: -

A Study of Pertuzumab With High-Dose Trastuzumab for the Treatment of Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer (MBC) With Central Nervous System (CNS) Progression Post-Radiotherapy

Phase: N/A Priority: Normal
NCT ID: NCT02536339 Org: User:
Start: 12/16/15 End: 12/29/20 Due: 12/29/21

A Study of Tenecteplase for Restoration of Function in Dysfunctional Central Venous Catheters

Phase: N/A Priority: Normal
NCT ID: NCT00395876 Org: User:
Start: 11/30/06 End: - Due: -

A Study Evaluating Topical Recombinant Human Vascular Endothelial Growth Factor (Telbermin) for Induction of Healing of Chronic, Diabetic Foot Ulcers

Phase: N/A Priority: Normal
NCT ID: NCT00069446 Org: User:
Start: 08/31/03 End: 10/31/04 Due: 10/31/05

A Study of Lebrikizumab in Healthy Japanese and Caucasian Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01423318 Org: User:
Start: 08/31/11 End: 02/29/12 Due: 02/28/13

A Study of Sunitinib in Combination With Bevacizumab, Carboplatin, and Paclitaxel in Patients With Advanced Non-Small Cell Lung Cancer (SABRE-L)

Phase: N/A Priority: Normal
NCT ID: NCT00434226 Org: User:
Start: 03/31/07 End: - Due: -

An Extension Study to Evaluate Safety and Tolerability of Ranibizumab in Macular Edema Secondary to Retinal Vein Occlusion (Cohort 2)

Phase: N/A Priority: Normal
NCT ID: NCT01442064 Org: User:
Start: 07/31/08 End: 07/31/10 Due: 07/31/11

A Study of the Comparable Efficacy and Safety of Pulmozyme (Dornase Alfa) Delivered by the eRapid Nebulizer System in Patients With Cystic Fibrosis

Phase: N/A Priority: Normal
NCT ID: NCT01712334 Org: User:
Start: 12/31/12 End: 06/30/13 Due: 06/30/14

GDC-0449 in Treating Patients With Locally Advanced or Metastatic Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00607724 Org: User:
Start: 04/30/07 End: 11/30/09 Due: 11/30/10

A Study to Determine the Relative Bioavailability of Capsule and Tablet Formulations of GDC-0941 and the Effect of Food and Proton Pump Inhibition on GDC-0941 Tablet Pharmacokinetics in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00999128 Org: User:
Start: 10/26/09 End: 02/26/10 Due: 02/26/11

A Study to Evaluate Raptiva in Adults With Moderate to Severe Plaque Psoriasis Who Are Candidates for Systemic Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00109317 Org: User:
Start: 09/30/02 End: 02/28/03 Due: 02/28/04

FOLFOX/Bevacizumab With Onartuzumab (MetMAb) Versus Placebo as First-Line Treatment in Patients With Metastatic Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01418222 Org: User:
Start: 09/14/11 End: 03/18/13 Due: 03/18/14

A Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patients With Active Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT01225393 Org: User:
Start: 11/30/10 End: - Due: -

Study of the Safety and Pharmacology of GDC-0980 in Combination With Paclitaxel With or Without Bevacizumab in Patients With Locally Recurrent or Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01254526 Org: User:
Start: 12/31/10 End: 04/30/13 Due: 04/30/14

Open-Label Study of the Long Term Safety of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis (IPF)

Phase: N/A Priority: Normal
NCT ID: NCT00662038 Org: User:
Start: 08/31/08 End: 02/29/16 Due: 02/28/17

A Study to Evaluate Avastin in Combination With Standard Chemotherapy to Treat Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00109070 Org: User:
Start: 09/30/00 End: 04/30/03 Due: 04/30/04

An Observational Study of the Use and Safety of Xolair® During Pregnancy

Phase: N/A Priority: Normal
NCT ID: NCT00373061 Org: User:
Start: 10/20/06 End: 01/05/18 Due: 01/05/19

An Observational Study of the Progression of Intermediate Age-Related Macular Degeneration

Phase: N/A Priority: Normal
NCT ID: NCT05300724 Org: User:
Start: 05/27/22 End: 06/30/27 Due: 06/30/28

A Study to Evaluate the Safety, Tolerability, and Activity of Intravenous MLDL1278A in Patients on Standard-of-Care Therapy for Stable Atherosclerotic Cardiovascular Disease (GLACIER)

Phase: N/A Priority: Normal
NCT ID: NCT01258907 Org: User:
Start: 03/31/10 End: - Due: -

A Study to Evaluate Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus (BELONG)

Phase: N/A Priority: Normal
NCT ID: NCT00626197 Org: User:
Start: 02/15/08 End: 10/28/13 Due: 10/28/14